North South Conflicts in Intellectual Property Rights
North South Conflicts in Intellectual Property Rights
North South Conflicts in Intellectual Property Rights
Vandana Shiva
To cite this article: Vandana Shiva (2000) North‐South Conflicts in Intellectual Property Rights,
Peace Review, 12:4, 501-508, DOI: 10.1080/10402650020014573
Vandana Shiva
T oday patents are associated with creativity and invention. They are an
exclusive right granted to an inventor to make, produce, distribute and sell
the patented product or use patented processes. However, patents have had
other functions and meanings in history. Patents have, through history, been
associated with colonization. At the beginning of colonization of the world by
Europe, they were aimed at the conquest of territory; now they are aimed at the
conquest of economies.
Letters, patents and charters created property rights to conquered lands. The
most frequent phrase in Columbus’ charter the Capitulaciones de Santa Fe, was the
dual verb “discover and conquer.” It was used seven times to assert rights to all
“islands and mainlands” before their discovery. The charter states:
ISSN 1040-265 9 print; ISSN 1469-998 2 online/00/040501-08 Ó 2000 Taylor & Francis Ltd
DOI: 10.1080/1040265002001457 3
502 Vandana Shiva
This charter makes patent the existence of “islands and mainlands” in the generative
formations of its language, and, in doing so, assigns proprietary jurisdictional authority
for that terrain to its would be, more accurately its “will-have-been-discoverer and
conqueror” as discoverer and conqueror.
These patents for discovery and conquest provide the background for the
contemporary con icts over patents generated by the General Agreement for
Trade and Tariffs (GATT) and the World Trade Organization (WTO), which
are often viewed as tools of recolonization by the Third World but viewed as
“natural” a right as conquest was during colonialism by Western powers.
There are, of course, differences in yesterday’s colonization and today’s
recolonization. Religion is not the ultimate justi cation for today’s conquest.
Recolonization is a “secular” project, but there is a new religion of the market
that drives this so-called secular project. Territory, gold and minerals are no
longer the objects of conquest. Markets and economic systems are what have to
be controlled. Knowledge itself has to be converted into property, just as land
was during colonization. This is why today “patents” have been covered by the
broader label of “intellectual property” or property in the “products of the
mind.” Just as land that was claimed to have been “discovered” and was treated
as “Terra Nullius” or empty land in spite of being inhabited by indigenous people
just because it was not inhabited by white Europeans, knowledge that is claimed
to have been “invented” and hence “patented” and converted to “intellectual
property” is often an existing innovation in indigenous knowledge systems.
The claim to invention, like the claim to discovery in the patent charters of
colonial conquest, is the justi cation for the take-over of market systems and
economic systems through globalized patent regimes. The cloak of reward to
inventiveness hides the real object—the control over the global economy. This
secular conquest of diverse knowledge systems and economies is at the heart of
the intense con icts and controversies on patents.
P atent laws in the U.S. are guided by myths on which today’s superpower
stands. The rst is the myth of discovery that went hand in hand with the
original de nition of the scope of letters patent that allowed it to be said that
Columbus discovered America. The second is the myth of ignorance as inno-
vation. This is categorically stated in the 1715 Connecticut law:
If any person or persons shall set themselves to work to discover any commodities that
may be of use for the country, for the bringing in a supply of goods from foreign parts,
that is not as yet of use among us, he that discovers it shall have due encouragement
granted to him.
The early U.S. Patent Laws, like European laws, were for introducing new
methods, which were unknown in the U.S. but practiced elsewhere. They were
not related to inventiveness, only to the fact that the practice was not being
undertaken within the sovereign’s domains, and hence could be treated as
“presumed to be unknown.”
Prior art and prior use in other countries was therefore systematically ignored
in U.S. laws on monopolies granted on the basis of claims to invention. The
same assumption of ignorance as invention is enshrined in the U.S. Patent
North–South Conicts in IPRs 503
Act of 1952. Section 102 of the Act treats as a prior art use in the U.S. and
publications in foreign countries. Use in foreign countries is not recognized as
prior art. Section 102 of the U.S. law, which de nes prior art, reads as follows:
Use in a foreign country therefore does not constitute prior art in U.S. patent
law.
Since patents are granted for new inventions, denial or non-recognition of
prior art elsewhere allows patents to be granted for existing knowledge and use
in other countries. This is the basis of biopiracy or knowledge of Indian
knowledge systems, and indigenous uses of biological resources being patented.
As Peter J. Thana has stated,
The statute talks about things that are publicly known and publicly used in this country
before the date of invention. You should not be able to claim as your invention,
something that was on the shelf, out there, before you invented it. Prior art excludes
devises in use elsewhere in the world. If, for example, somebody in Europe were
operating a machine and you independently and without knowledge of the existence in
good faith developed your own invention that was essentially the same machine, that fact
would not prevent you from obtaining a patent in the U.S. The European invention
would not be considered prior art in the statute.
The U.S. statute, which was designed to make the U.S. an independent
industrial power, was thus deliberately designed to deny prior art and hence treat
ignorance of prior innovation as the grounds of invention. Paradoxically, a legal
system aimed at preventing “intellectual piracy” is itself based on legitimizing
piracy.
This is the reason that neem, turmeric, ginger, bitter gourd, and basmati have
been patented. Biopiracy has emerged as an intrinsic part of Western industrial
IPR regimes that have now been globalized through the Trade Related Intellec-
tual Property Rights Agreement (TRIPs) of the WTO. The need for TRIPs
reform, and reform in Northern IPR regimes is therefore of utmost urgency.
patent of ce. In 1971, General Electric and one of its employees, Anand Mohan
Chakravarty, applied for a U.S. patent on genetically engineered pseudomonas
bacteria. Taking plasmids from three kinds of bacteria, Chakravarty transplanted
them into a fourth. As he explained, “I simply shuf ed genes, changing bacteria
that already existed.” Chakravarty was granted his patent on the grounds that
the micro-organism was not a product of nature, but was his invention and,
therefore, patentable. As Andrew Kimbrell, a leading U.S. lawyer, recounts, “In
coming to its precedent-shattering decision, the court seemed unaware that the
inventor himself had characterized his ‘creation’ of the microbe as simply
‘shifting’ genes, not creating life.”
On such slippery grounds, the rst patent on life was granted, and, in spite of
the exclusion of plants and animals from patenting under U.S. law, the United
States has since rushed to grant patents on all kinds of life forms. Currently, well
over 190 genetically engineered animals, including sh, cows, mice, and pigs, are
guratively standing in line to be patented by a variety of researchers and
corporations. According to Kimbrell, “The Supreme Court’s Chakravarty de-
cision has been extended to be continued up the chain of life. The patenting of
microbes has led inexorably to the patenting of plants, and then animals.”
Biodiversity has been rede ned as “biotechnological inventions” to make the
patenting of life forms appear less controversial. These patents are valid for 20
years and, hence, cover future generations of plants and animals. Yet even when
scientists in universities or corporations shuf e genes, they do not “create” the
organism that they then patent.
Referring to the landmark Chakravarty case, in which the court found that he
had “produced a new bacterium with markedly different characteristics than any
found in nature,” Key Dismukes, Study Director for the Committee on Vision
of the National Academy of Sciences in the United States, said:
Let us at least get one thing straight: Anand Chakravarty did not create a new form of
life; he merely intervened in the normal processes by which strains of bacteria exchange
genetic information, to produce a new strain with an altered metabolic pattern. “His”
bacterium lives and reproduces itself under the forces that guide all cellular life. Recent
advances in recombinant DNA techniques allow more direct biochemical manipulation
of bacterial genes than Chakravarty employed, but these too are only modulations of
biological processes. We are incalculably far away from being able to create life de novo,
and for that I am profoundly grateful. The argument that the bacterium is Chakravarty’s
handiwork and not nature’s wildly exaggerates human power and displays the same
hubris and ignorance of biology that have had such devastating impact on the ecology
of our planet.
This major shift in the scope of patentability was not the result of any debate
in parliament or among the public, but of a patent of ce. Patents on life were
then globalized by a decision made during the Uruguay Round of GATT to
include IPRs in trade treaties, and to include life in IPR regimes. TRIPs was
drafted and pushed by industry. As James Enyart of Monsanto has stated,
Besides selling our concepts at home, we went to Geneva where [we] present [our]
document to the staff of the GATT Secretariat. We also took the opportunity to present
it to the Geneva based representatives of a large number of countries. … What I have
described to you is absolutely unprecedented in GATT. Industry has identi ed a major
North–South Conicts in IPRs 505
Parties may exclude from patentability plants and animals other than microorganisms,
and essentially biological processes for the production of plants or animals other than
non-biological and microbiological processes. However, parties shall provide for the
protection of plant varieties either by patents or by an effective sui generis system or by
any combination thereof. This provision shall be reviewed four years after the entry into
force of the Agreement establishing the WTO.
The period for the review of TRIPs has therefore begun in 1999. While most
Third World countries wanted TRIPs changed to prevent patents on life and
biopiracy, the U.S. is upholding the patenting of life forms and indigenous
knowledge.
I n granting the rst patent on life in 1980, the U.S. Supreme Court interpreted
life as “manufacture” and “constitution of matter.” This started the slide down
the slippery slope of patenting seeds, cows, sheep, human cells and micro-organ-
isms. The U.S. is proud of having started a perverse trend based on awed
scienti c assumptions that ignore the self-organizing, dynamic, interactive nature
of life forms, de ning them as mere “constitution of matter.” As the U.S. paper
on the TRIPs review states, “The Supreme Court’s decision in Diamond,
Commissioner of Patents and Trademarks vs. Chakrabarty spurred the develop-
ment of a new industry—the biotechnology industry.”
The U.S. is committed to patents on life in order to defend its biotechnology
industry. Having opened the ood gates to treating life forms and these
modi cations as patentable, the U.S. patent of ce started to grant patents not
just to genetically modi ed organisms (GMOs), but to process and products
derived from indigenous knowledge of biological resources. This is how patents
on neem, karela, and basmati have been given in the U.S. Instead of recognizing
that it is promoting piracy and changing its laws to prevent its practice, the U.S.
has rejected all Third World proposals for the recognition and protection of
indigenous knowledge.
The U.S. states that requiring patent applicants to identify the source of
genetic materials or traditional knowledge used in developing their claim “would
be impractical.” Recognizing indigenous knowledge should be a necessary
element of the test for inventiveness and novelty that is required under any
patent system. However, when it comes to traditional knowledge, this screening
for prior art is declared as impractical. Forcing all countries to change their
patent laws in spite of protests is considered practical. Imposing patents on life
on people in the North and South who reject patents on life is considered
practical. Changing the world’s cultures and enforcing property rights on seed is
considered practical. Collecting royalties from the poor in the Third World for
506 Vandana Shiva
resources and knowledge that came from them in the rst place is considered
practical. But taking the simple step to change one clause in one law in the U.S.
and one clause in TRIPs is considered impractical. This suggests that the U.S.
is committed to promoting biopiracy.
TRIPs and U.S. style patent laws annihilate the rights of Third World
communities by not having any system of recognition and protection of indige-
nous knowledge. Biopiracy is intellectual and cultural rape. It is the slavery of the
new millennium, and there is only one way to stop it—to make it illegal in
international law by changing TRIPs. Anything short of stopping biopiracy
through reforming TRIPs is participation in a crime against nature and the poor.
W hen TRIPs was forced on countries during the Uruguay Round, many
issues of public concern were bypassed and the full ethical, ecological and
economic implications of patenting life were not discussed. Third World coun-
tries were coerced into accepting the Western style IPR system. As a result of
sustained public pressure after the agreement came into force in 1995, many
Third World countries have made recommendations for changes in Article 27.3
(b) to prevent biopiracy.
In a discussion paper submitted to the TRIPs Council in Geneva concerning
the patenting of life forms, the Indian Government wrote that:
Patenting of life forms may have at least two dimensions. Firstly, there is the ethical
question of the extent of private ownership that could be extended to life forms. The
second dimension relates to the use of IPRs concept as understood in the industrialized
world and its appropriateness in the face of the larger dimension of rights on knowledge,
their ownership, use, transfer and dissemination. Informal systems, e.g. the “shrutis” and
“smritis” in the Indian tradition and grandmother’s potions all over the world get scant
recognition. To create systems that fail to address this issue can have severe adverse
consequences on mankind, some say even leading to extinction.
A nother aw of TRIPs that is also rooted in using the U.S. Patent as the
model is the introduction of patents on life forms through Article 27.3(b).
This Article was to be reviewed during the last WTO Seattle Ministerial
Conference. Bolivia, Columbia, Ecuador, Nicaragua and Peru submitted a
proposal, Protection of Intellectual Property Rights Relating to the Traditional
Knowledge of Local and Indigenous Communities. The paper states that:
The entire modern evolution of intellectual property has been framed by principles and
systems which have tended to leave aside a large sector of human creativity, namely the
traditional knowledge possessed by local and indigenous communities.
O n May 10, the anniversary of the launch of the rst Indian movement for
independence, a major milestone was crossed in the contemporary move-
ment of freedom from biocolonialism and biopiracy. The European Patent
Of ce (EPO) struck down Patent No. 0436257 B1, jointly held by the U.S.
Government and the multinational W.R. Grace, as based on the piracy of
existing knowledge, and lacking in novelty and inventiveness. U.S.D.A. and
W.R. Grace had led the Patent on December 12, 1990. On September 14,
1994, the European Patent Of ce granted a patent for
A method for controlling fungi on plants comprising contacting the fungi with a neem
oil formulation containing 0.1 to 10% of a hydrophobic extracted neem oil which is
substantially free of azadirachtin, 0.005 to 50% of emulsifying surfactant, and 0 to 99%
water.
years, we brought every possible evidence to bear on the case through af davits
from farmers and scientists.
The work for the “Neem Challenge” started in 1994 when I rst read about
the neem patents in a journal. We launched the “Neem Campaign” in India,
and formed the “Neem Team”—an international network of patent warriors to
support our national campaign. We started the campaign because of the
importance of neem in our culture, our agriculture and our health systems. We
picked the fungicide patent because it was owned by the U.S. Government and
a big multinational corporation (MNC). It was therefore a powerful symbol of
biopiracy and the aws of Western industrial IPR systems. Neem is an important
symbol because it is used on a large scale for medicine and agriculture in India.
If biopiracy can occur with such commonly used knowledge, what would be the
fate of less prevalent examples of traditional innovation? Neem was also import-
ant because it is an ecologically sound alternative to hazardous pesticides. Our
campaign “No more Bhopals, plant a neem” started in 1984 at the time of the
Bhopal disaster. Neem has been a central part of the ecological and sustainable
agriculture work that we have done in India through national networks on
organic farming. Finally, neem is a symbol of freedom as the “Free Tree.” Its
scienti c name, Azadirachtin Indica, is derived from Azad Darakt which means free
tree. Liberating the free tree thus became the symbol of our liberation movement
to free knowledge systems and biodiversity from biopiracy.
The neem battle has been described as one between Davids and Goliaths—the
Davids being three women and their organizations, the Goliaths being a
superpower and a major multinational corporation. The USDA and Grace
attorneys tried every argument under the sun to dismiss the case and block the
proceedings, including procedural arguments that as an Indian I could not bring
a case to the EPO and that the Research Foundation had not paid a $2,000 fee.
Working together as friends and colleagues over more than a decade, Linda
Bullard, Magda Alvoet, and others in the movement against biopiracy evolved
creative ways to challenge money power with moral power, and the might of
corporations and governments with solidarity. In this case David won and on the
afternoon of May 10, 2000 the patent was revoked! Freeing the free tree was part
of an experiment in nding new ways to defend liberty in an era of biocolonial-
ism.
Vandana Shiva is a physicist, environmental activist, and Director of the Research Foundation for
Science, Technology and Natural Resource Policy. She has been a visiting professor and has lectured
at the University of Oslo, Norway, Schumacher College, U.K., and Mt. Holyoke College, U.S. She
currently lectures at York University, Canada, the University of Lulea, Sweden, the University of
Victoria, Canada, and organizations and institutions worldwide on the environment, feminism and
economic development. Besides her academic and research contributions, she has also served as an
adviser to governments in India and abroad as well as NGOs, such as, The International Forum on
Globalization, Women’s Environment and Development Organization and Third World Network.
She was the winner of the Right Livelihood Award for 1993. Her books include Stolen Harvest, Biopiracy,
Monocultures of the Mind, The Violence of the Green Revolution, and Staying Alive. Correspondence: Director
Research Foundation for Science, Technology and Ecology, A-60, Hauz Khas, New Delhi–110 016,
India. E-mail: vshiva@giasdl01.vsnl.net.in